advertisement
FDA rejects Claritin, Singulair combo med
The U.S. Food and Drug Administration (FDA) has turned down an application for a combo allergy drug. The medication would have combined the allergy medication Claritin with the asthma, allergy drug Singulair. Drugmakers Merck and Schering-Plough issued statements that they were still evaluating the FDA's response. Experts stress that both medications will continue to be offered separately.
(The Associated Press) UPDATED 04/27/2008Click here to read the full story
Conditions: | allergies - 54 Articles | asthma - 268 Articles Treatments: | antihistamines - 8 Articles | Singulair - 26 Articles
Helpful?
advertisement
